1025.4000 -5.10 (-0.49%)
NSE Jul 16, 2025 15:31 PM
Volume: 86,741
 

1025.40
-0.49%
BOB Capital Markets Ltd.
Q4 revenue growth at 11% YoY led by broad-based domestic uptick and 17% growth in the US; ROW declined 19% YoY
Alembic Pharmaceuticals Ltd. has gained 21.14% in the last 3 Months
More from Alembic Pharmaceuticals Ltd.
Recommended